There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.
The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.
Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.
Comments